Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Glatiramer acetate-induced lobular panniculitis and skin necrosis.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
The multifaceted role of astrocytes in regulating myelination.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
[Neurological complications during treatment of the tumor necrosis alpha inhibitors].
Teriflunomide.
A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis.
[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.]
Oral therapy approved for multiple sclerosis.
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation.
Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgG-positive acute polyneuropathy.
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.
Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization.
Extracellular RNAs: development as biomarkers of human disease.
Reversed takotsubo cardiomyopathy in a patient with new-onset multiple sclerosis: Cause, link, or just coincidence?
Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
Randomized trial of erhuangfang for relapsing multiple sclerosis.
Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclesis.
Pages
« first
‹ previous
…
635
636
637
638
639
640
641
642
643
…
next ›
last »